Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective
Diyang Xie, Jieyi Shi, Jian Zhou, Jia Fan, Qiang Gao
Clin Mol Hepatol. 2023;29(2):206-216.   Published online 2022 Dec 22     DOI: https://doi.org/10.3350/cmh.2022.0402
Citations to this article as recorded by Crossref logo
Triterpenes from Ganoderma lucidum inhibit hepatocellular carcinoma by regulating enhancer-associated lncRNA in vivo
Ruolin Zhao, Caiyun Zhang, Chenchen Tang, Xinxin Wu, Sheng Hu, Qingqiong Luo, Ning Jia, Lingzhi Fan, Yixing Wang, Wencheng Jiang, Qilong Chen
Journal of Ethnopharmacology.2025; 336: 118706.     CrossRef
Massive extrapancreatic solid pseudopapillary neoplasm misdiagnosed as hepatic tumor: a case report and literature review
Jixu Guo, Qingjuan Zhao, Liting Qin, Shengjie Xie, Shiliu Lu, Baibei Li, Meilin He, Linhong Xie, Shuiping Yu
Frontiers in Oncology.2024;[Epub]     CrossRef
A novel nomogram to predict the overall survival of early-stage hepatocellular carcinoma patients following ablation therapy
Honghai Zhang, Shugui Sheng, Wenying Qiao, Ming Han, Ronghua Jin
Frontiers in Oncology.2024;[Epub]     CrossRef
Novel insights into small open reading frame-encoded micropeptides in hepatocellular carcinoma: A potential breakthrough
Qiangnu Zhang, Liping Liu
Cancer Letters.2024; 587: 216691.     CrossRef
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
Josep M. Llovet, Roser Pinyol, Mark Yarchoan, Amit G. Singal, Thomas U. Marron, Myron Schwartz, Eli Pikarsky, Masatoshi Kudo, Richard S. Finn
Nature Reviews Clinical Oncology.2024; 21(4): 294.     CrossRef
Nomogram for Predicting Postoperative Pulmonary Metastasis in Hepatocellular Carcinoma Based on Inflammatory Markers
Huanjie Zhou, Haiping Zheng, Ying Wang, Ming Lao, Hong Shu, Meifang Huang, Chao Ou
Cancer Control.2024;[Epub]     CrossRef
KDM4A-AS1 Promotes Cell Proliferation, Migration, and Invasion via the miR-4306/STX6 Axis in Hepatocellular Carcinoma
Wei Cao, Yuhan Ren, Ying Liu, Guoshu Cao, Zhen Chen, Fan Wang
Critical Reviews in Eukaryotic Gene Expression.2024; 34(4): 55.     CrossRef
Development of Shark Single Domain Antibodies Specific for Human α-Fetoprotein and the Multimerization Strategy in Serum Detection
Zheming Wang, Xiaoxia Xie, Zhenyun He, Zhichang Sun, Yongli Zhang, Fujing Mao, Hua Pei, Sihang Zhang, Bruce D. Hammock, Xing Liu
Analytical Chemistry.2024; 96(10): 4242.     CrossRef
The significance of m6A RNA methylation regulators in diagnosis and subtype classification of HBV-related hepatocellular carcinoma
Qijuan Zang, Yalin Ju, Siyi Liu, Shaobo Wu, Chengbin Zhu, Liangru Liu, Weicheng Xu, Yingli He
Human Cell.2024; 37(3): 752.     CrossRef
Pre-operative enhanced magnetic resonance imaging combined with clinical features predict early recurrence of hepatocellular carcinoma after radical resection
Jian-Ping Chen, Ri-Hui Yang, Tian-Hui Zhang, Li-An Liao, Yu-Ting Guan, Hai-Yang Dai
World Journal of Gastrointestinal Oncology.2024; 16(4): 1192.     CrossRef
Interim analysis of the PARADISE study: Benefits of add-on peginterferon-α in NA-treated patients with CHB
Shaowen Jiang, Simin Guo, Yan Huang, Jie Xu, Yi Li, Yilan Zeng, Yuan Guo, Lijuan Ouyang, Chuanwu Zhu, Weifeng Zhao, Qin Zhang, Qing Guo, Haiguang Xin, Qing Xie
Antiviral Research.2024; 226: 105892.     CrossRef
Hepatocellular Carcinoma: Current Drug Therapeutic Status, Advances and Challenges
Shunzhen Zheng, Siew Wee Chan, Fei Liu, Jun Liu, Pierce Kah Hoe Chow, Han Chong Toh, Wanjin Hong
Cancers.2024; 16(8): 1582.     CrossRef
Clinical efficacy of lenvatinib, trans-arterial chemoembolization, and PD-1/L1 inhibitors in advanced hepatocellular carcinoma: a systematic review and network meta-analysis
YiFeng Liang, LiMing Gan, DeJin Zeng, LangHua Lin, ZheKun Xiong, FangLian Liao, ALing Wang
Clinical and Translational Oncology.2024; 26(10): 2652.     CrossRef
Higher objective responses by hepatic arterial infusion chemotherapy following atezolizumab and bevacizumab failure than when used as initial therapy in hepatocellular carcinoma: a retrospective study
Jae-Sung Yoo, Ji Hoon Kim, Hee Sun Cho, Ji Won Han, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Suho Kim, Jung Suk Oh, Ho Jong Chun, Pil Soo Sung
Abdominal Radiology.2024; 49(9): 3127.     CrossRef
Conversion therapy for advanced hepatocellular carcinoma in the era of precision medicine: Current status, challenges and opportunities
Ming‐Da Wang, Xue‐Jun Xu, Ke‐Chun Wang, Yong‐Kang Diao, Jia‐Hao Xu, Li‐Hui Gu, Lan‐Qing Yao, Chao Li, Guo‐Yue Lv, Tian Yang
Cancer Science.2024; 115(7): 2159.     CrossRef
Dual-molecular targeting nanomedicine upregulates synergistic therapeutic efficacy in preclinical hepatoma models
Qilong Wang, Xiwei Sun, Xizhu Fang, Zhongying Wang, Haodong Wang, Siqiao Sun, Shuai Wang, Tingting Li, Ping Zhang, Zhihua Cheng
Acta Biomaterialia.2024; 183: 306.     CrossRef
Research Progress on the Role of Epigenetic Methylation Modification in Hepatocellular Carcinoma
Jing Wang, Wenyue Gao, Hongbo Yu, Yuting Xu, Changchuan Bai, Qingwei Cong, Ying Zhu
Journal of Hepatocellular Carcinoma.2024; Volume 11: 1143.     CrossRef
Comprehensive Bioinformatics Analysis and Machine Learning of TTK as a Transhepatic Arterial Chemoembolization Resistance Target in Hepatocellular Carcinoma
Yangyang Xiao, Youwen Hu
Molecular Biotechnology.2024;[Epub]     CrossRef
TRIM33 enhances the ubiquitination of TFRC to enhance the susceptibility of liver cancer cells to ferroptosis
Wenjing Ji, Weibin Zhang, Xin Zhang, Yue Ke
Cellular Signalling.2024; 121: 111268.     CrossRef
Breaking Down the Arsenal: Recent Progress in the Nanotherapeutic Strategies for Hepatocellular Carcinoma Treatment
Sumit Roy, Vancha Harish, Sharfuddin Mohd, Sachin Kumar Singh
Advanced Therapeutics.2024;[Epub]     CrossRef
Effectiveness and safety of vascular intervention plus lenvatinib versus vascular intervention alone for hepatocellular carcinoma patients with portal vein tumor thrombus: a retrospective comparative study
Saikang Tang, Yingming Gao, Xue Yan, Weihua Zhi, Yue Han
Frontiers in Oncology.2024;[Epub]     CrossRef
Efficacy and safety of apatinib plus immune checkpoint inhibitors and transarterial chemoembolization for the treatment of advanced hepatocellular carcinoma
Jianfei Wu, Xuefeng Bai, Guodong Yu, Quan Zhang, Xixi Tian, Yuan Wang
Journal of Cancer Research and Clinical Oncology.2024;[Epub]     CrossRef
The potential of lenvatinib in breast cancer therapy
Yuefeng Shang, Tong Liu, Wenjing Wang
Medical Oncology.2024;[Epub]     CrossRef
Evaluating the impact of treatment sequencing on outcomes in hepatocellular carcinoma: a comparative analysis of TACE and systemic therapies
XingRong Zheng, Xin Song, BoXiang Zhang, XiYao Chen, YeQiong Zhang, QiuMin Luo, ZhiPeng Li, ZheXuan Deng, RuiXuan Xu, Liang Peng, Chan Xie
Clinical and Experimental Medicine.2024;[Epub]     CrossRef
Multi‐stage automatic and rapid ablation and needle trajectory planning method for CT‐guided percutaneous liver tumor ablation
Shengwei Li, Fanyu Zhou, Yumeng Zhang, Sheng Xu, Yufeng Wang, Lin Cheng, Zhixin Bie, Bin Li, Xiao‐Guang Li
Medical Physics.2024;[Epub]     CrossRef
Management of hepatocellular carcinoma in China: Seeking common grounds while reserving differences
Tian Yang, Ming-Da Wang, Xin-Fei Xu, Chao Li, Han Wu, Feng Shen
Clinical and Molecular Hepatology.2023; 29(2): 342.     CrossRef
The clinical management of hepatocellular carcinoma in China: Progress and challenges
Shan Shan, Jidong Jia
Clinical and Molecular Hepatology.2023; 29(2): 339.     CrossRef
A bibliometric study on the utilization of lenvatinib in hepatocellular carcinoma (2014–2022)
Cong-Cong Wang, Cai-Yan Yu, Jing Zhang, Rui Wang, Xiang-Shuo Kong
Frontiers in Pharmacology.2023;[Epub]     CrossRef
PEG-grafted arsenic trioxide-loaded mesoporous silica nanoparticles endowed with pH-triggered delivery for liver cancer therapy
Liangdi Jiang, Xuerui Wang, Faisal Raza, Hongyu Zhong, Jing Su, Wei-En Yuan, Mingfeng Qiu
Biomaterials Science.2023; 11(15): 5301.     CrossRef
From clinical variables to multiomics analysis: a margin morphology-based gross classification system for hepatocellular carcinoma stratification
Zhongqi Fan, Meishan Jin, Lei Zhang, Nanya Wang, Mingyue Li, Chuanlei Wang, Feng Wei, Ping Zhang, Xiaohong Du, Xiaodong Sun, Wei Qiu, Meng Wang, Hongbin Wang, Xiaoju Shi, Junfeng Ye, Chao Jiang, Jianpeng Zhou, Wengang Chai, Jun Qi, Ting Li, Ruoyan Zhang,
Gut.2023; 72(11): 2149.     CrossRef
Heterogeneity characterization of hepatocellular carcinoma based on the sensitivity to 5-fluorouracil and development of a prognostic regression model
Xinyu Gu, Shuang Li, Xiao Ma, Di Huang, Penghui Li
Frontiers in Pharmacology.2023;[Epub]     CrossRef
Tips for Preparing and Practicing Thermal Ablation Therapy of Hepatocellular Carcinoma
Yasunori Minami, Tomoko Aoki, Satoru Hagiwara, Masatoshi Kudo
Cancers.2023; 15(19): 4763.     CrossRef
A novel signature of the ligand and receptor genes associated with disulfidoptosis for prediction of prognosis, immunologic therapy responses in hepatocellular carcinoma
Chong Fu, Chang Cheng, Yanping Zhang
Heliyon.2023; 9(9): e19502.     CrossRef
Effect of intermittent Pringle maneuver on perioperative outcomes and long-term survival following liver resection in patients with hepatocellular carcinoma: a meta-analysis and systemic review
Lingbo Hu, Aidong Wang, Yingli Qiao, Xiandan Huang
World Journal of Surgical Oncology.2023;[Epub]     CrossRef